InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
0
T+90 hit rate
46%
T+90 mean return
-17.1%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by RAPP EDWARD J, Director. Director active across 2 companies, notably AbbVie Inc.. Aggregated, 31 disclosures have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €1m. Activity tracked since 7 May 2021. The latest transaction was disclosed on 8 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations31 total
1,118 shares0Common Stock, $0.01 par valueSEC:0001171780-26-000010:0
1,203 shares0Common Stock, $0.01 par valueSEC:0001415889-25-012792:0
1,407 shares0Common StockSEC:0001819493-25-000056:0
1,475 shares0Common StockSEC:0001819493-25-000029:0
1,065 shares0Common StockSEC:0001819493-25-000010:0
1,065 shares0Common StockSEC:0001819493-24-000206:0
28,694 shares0Common StockSEC:0001819493-24-000115:0
1,322 shares0Common Stock, $0.01 par valueSEC:0001415889-24-012528:0
445 shares0Common StockSEC:0001819493-24-000052:0
650 shares0Common StockSEC:0001819493-24-000012:0
15,151 shares0Common StockSEC:0001819493-23-000239:0
15,151 shares0Common StockSEC:0001819493-23-000190:0
444,444 shares0Common StockSEC:0001819493-23-000142:0
1,450 shares0Common Stock, $0.01 par valueSEC:0001415889-23-007674:0
7,936 shares0Common StockSEC:0001819493-23-000068:0
7,936 shares0Common StockSEC:0001819493-23-000015:0
300,000 shares@ US$0.6919.8% of flowCommon StockSEC:0001819493-22-000174:0
Ideal exit: 27 Aug 2023 (T+270)
3,378 shares0Common StockSEC:0001819493-22-000129:0
115,606 shares0Common StockSEC:0001819493-22-000101:0
3,816 shares0Common StockSEC:0001819493-22-000063:0
1,421 shares0Common Stock, $0.01 par valueSEC:0001179110-22-002930:0
1,474 shares0Common StockSEC:0001209191-22-000914:0
1,474 shares0Common StockSEC:0001209191-22-000914
100,000 shares@ US$4.26821.46% mcap46.5% of flowCommon StockSEC:0001209191-21-066161:0
Ideal exit: 15 Aug 2022 (T+270)
100,000 shares@ US$4.26821.46% mcap93.1% of flowCommon StockSEC:0001209191-21-066161
Ideal exit: 15 Aug 2022 (T+270)
25 of 31 declarations
About RAPP EDWARD J
Edward J. Rapp is a Board Member at AbbVie Inc. and Xos, Inc. He brings expertise in corporate governance and business strategy. His role involves overseeing operations and advising management on best practices in governance.
